Anti-dementia
Anti-dementia drugs are drugs for the treatment of dementia .
Antidementia drugs with little scientifically proven effect
The anti-dementia drugs with little proven effectiveness include the acetylcholinesterase inhibitors donepezil (Aricept), rivastigmine (Exelon), galantamine (Reminyl) and the NMDA antagonist memantine (Ebixa, Axura).
There is no significant difference in effectiveness between the individual preparations. The effectiveness varies from person to person. There are no symptoms or findings from technical examinations that can be used to predict whether an antidementia will work in a patient. If antidementia drugs are prescribed, the treated patient should be given a neuropsychological examination beforehand, at least for orientation , and the relatives should be interviewed. The testing and questioning of relatives should be repeated after three months. If the dementia has worsened significantly, the preparation must be considered ineffective and should be discontinued or replaced with another.
Antidementia drugs with no scientifically proven effect
In addition to the preparations mentioned, there are numerous drugs whose effect on dementia has not yet been scientifically proven. These preparations operate under the term nootropics . These include ginkgo , centrophenoxine , calcium antagonists (such as cinnarizine , nimodipine ), nicergoline , piracetam , pentoxifylline , cyclandelate , pyritinol and calf blood hemolysate.
literature
- Hans-Dieter Schweiger: Alzheimer's dementia: antidementia drugs against the gradual breakdown . In: Pharmazeutische Zeitung , 34/2008
Web links
- Antidementia drugs . Nursing wiki
Individual evidence
- ↑ Definition of anti-dementia . Neurologists and psychiatrists online; accessed on February 16, 2015.
